BUI Fundamental Analysis - BARBARA BUI

Fundamental Rating

Overall BUI gets a fundamental rating of 2 out of 10. We evaluated BUI against 51 industry peers in the Textiles, Apparel & Luxury Goods industry. BUI may be in some trouble as it scores bad on both profitability and health. BUI is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BUI has reported negative net income.

BUI had a positive operating cash flow in the past year.

In multiple years BUI reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: BUI reported negative operating cash flow in multiple years.

1.2 Ratios

BUI has a worse Return On Assets (-4.19%) than 83.33% of its industry peers.

Looking at the Return On Equity, with a value of -72.21%, BUI is doing worse than 93.75% of the companies in the same industry.

The Return On Invested Capital of BUI (4.45%) is worse than 66.67% of its industry peers.

		Industry Rank	Sector Rank
ROA	-4.19%
ROE	-72.21%
ROIC	4.45%

ROA(3y)0.46%

ROA(5y)-6.8%

ROE(3y)1.78%

ROE(5y)-33.1%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of BUI (2.90%) is worse than 77.08% of its industry peers.

With an excellent Gross Margin value of 74.75%, BUI belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.

BUI's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	2.9%
PM (TTM)	N/A
GM	74.75%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.25%

GM growth 5Y2.61%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BUI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

BUI has about the same amout of shares outstanding than it did 1 year ago.

BUI has less shares outstanding than it did 5 years ago.

BUI has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.87, we must say that BUI is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 0.87, BUI is not doing good in the industry: 87.50% of the companies in the same industry are doing better.

The Debt to FCF ratio of BUI is 19.32, which is on the high side as it means it would take BUI, 19.32 years of fcf income to pay off all of its debts.

BUI's Debt to FCF ratio of 19.32 is on the low side compared to the rest of the industry. BUI is outperformed by 75.00% of its industry peers.

BUI has a Debt/Equity ratio of 7.81. This is a high value indicating a heavy dependency on external financing.

BUI has a worse Debt to Equity ratio (7.81) than 95.83% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	7.81
Debt/FCF	19.32
Altman-Z	0.87

ROIC/WACC0.6

WACC7.43%

2.3 Liquidity

BUI has a Current Ratio of 1.00. This is a normal value and indicates that BUI is financially healthy and should not expect problems in meeting its short term obligations.

With a Current ratio value of 1.00, BUI is not doing good in the industry: 87.50% of the companies in the same industry are doing better.

BUI has a Quick Ratio of 1.00. This is a bad value and indicates that BUI is not financially healthy enough and could expect problems in meeting its short term obligations.

BUI's Quick ratio of 0.67 is on the low side compared to the rest of the industry. BUI is outperformed by 70.83% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1
Quick Ratio	0.67

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BUI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.79%.

BUI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.73%.

Measured over the past years, BUI shows a small growth in Revenue. The Revenue has been growing by 1.80% on average per year.

EPS 1Y (TTM)-47.79%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-136.86%

Revenue 1Y (TTM)6.73%

Revenue growth 3Y10.13%

Revenue growth 5Y1.8%

Sales Q2Q%13.27%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BUI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BUI is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	10.57
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BUI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BARBARA BUI

EPA:BUI (11/20/2025, 7:00:00 PM)

4.48

-0.02 (-0.44%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryTextiles, Apparel & Luxury Goods

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners65.34%

Ins Owner ChangeN/A

Market Cap3.00M

Revenue(TTM)13.16M

Net Income(TTM)-504.00K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.23
P/FCF	10.57
P/OCF	6.31
P/B	4.3
P/tB	5.57
EV/EBITDA	N/A

EPS(TTM)-0.75

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.42

FCFY9.46%

OCF(TTM)0.71

OCFY15.86%

SpS19.64

BVpS1.04

TBVpS0.8

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.19%
ROE	-72.21%
ROCE	6.05%
ROIC	4.45%
ROICexc	6.57%
ROICexgc	6.83%
OM	2.9%
PM (TTM)	N/A
GM	74.75%
FCFM	2.16%

ROA(3y)0.46%

ROA(5y)-6.8%

ROE(3y)1.78%

ROE(5y)-33.1%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.25%

GM growth 5Y2.61%

F-Score4

Asset Turnover1.09

Health

		Industry Rank	Sector Rank
Debt/Equity	7.81
Debt/FCF	19.32
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	1.46%
Interest Coverage	250
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1
Quick Ratio	0.67
Altman-Z	0.87

F-Score4

WACC7.43%

ROIC/WACC0.6

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)1.69%

Cap/Sales(5y)9.5%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-47.79%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-136.86%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)6.73%

Revenue growth 3Y10.13%

Revenue growth 5Y1.8%

Sales Q2Q%13.27%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y194.32%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-32.38%

FCF growth 3Y1.7%

FCF growth 5YN/A

OCF growth 1Y-40.87%

OCF growth 3Y-10.52%

OCF growth 5YN/A

BARBARA BUI / BUI.PA FAQ

Can you provide the ChartMill fundamental rating for BARBARA BUI?

ChartMill assigns a fundamental rating of 2 / 10 to BUI.PA.

Can you provide the valuation status for BARBARA BUI?

ChartMill assigns a valuation rating of 2 / 10 to BARBARA BUI (BUI.PA). This can be considered as Overvalued.

What is the profitability of BUI stock?

BARBARA BUI (BUI.PA) has a profitability rating of 2 / 10.

How financially healthy is BARBARA BUI?

The financial health rating of BARBARA BUI (BUI.PA) is 2 / 10.

BARBARA BUI (BUI.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BARBARA BUI / BUI.PA FAQ

Can you provide the ChartMill fundamental rating for BARBARA BUI?

Can you provide the valuation status for BARBARA BUI?

What is the profitability of BUI stock?

How financially healthy is BARBARA BUI?